Keywords: losses, grow, amylin, costly, phase, iii, trials

Losses grow at Amylin on costly Phase III trials

Article | 19 May 2003

Print This

San Diego, USA-based Amylin Pharmaceuticals has reported a sharp increase in net loss for the first quarter of 2003, on the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in